{"transactions":[{"id":905314,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":66506,"kind":"person","name":"Balta Elizabeth","position":1,"cik":"0001884087","reported_name":"Balta Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-14T01:00:37.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase shares of the Issuer's common stock, one quarter of which will vest on February 15, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":168750,"derivative":{"exercise_price":14.81,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001193125-26-052055","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000119312526052055/ownership.xml","form_type":"4"}},{"id":905313,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":66506,"kind":"person","name":"Balta Elizabeth","position":1,"cik":"0001884087","reported_name":"Balta Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-14T01:00:37.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). 1/4 of the total number of RSUs granted shall vest on each of the first four anniversaries of February 15, 2026, the vesting commencement date, subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":28125,"source":{"system":"sec-edgar","filing":"0001193125-26-052055","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000119312526052055/ownership.xml","form_type":"4"}},{"id":2006299,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":66506,"kind":"person","name":"Balta Elizabeth","position":1,"cik":"0001884087","reported_name":"Bekiroglu Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-17T19:13:07.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on February 15, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":9.06,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-010915","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000120919123010915/doc4.xml","form_type":"4"}},{"id":2013123,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":66506,"kind":"person","name":"Balta Elizabeth","position":1,"cik":"0001884087","reported_name":"Bekiroglu Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec."}}],"security":"Common Stock","published_at":"2023-02-15T20:12:48.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":5922,"price":10.6926,"value":63321.5772,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover the applicable withholding taxes upon settlement of restricted stock units issued to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.41 to $11.02. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":103007,"source":{"system":"sec-edgar","filing":"0001209191-23-009920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000120919123009920/doc4.xml","form_type":"4"}},{"id":2117337,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":66506,"kind":"person","name":"Balta Elizabeth","position":1,"cik":"0001884087","reported_name":"Bekiroglu Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-14T19:08:09.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":88900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3rd) of the shares subject to the option shall vest on each of the first three anniversaries of November 10, 2022, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":88900,"derivative":{"exercise_price":2.47,"expiration_date":"2032-11-09","underlying":"Common Stock","underlying_shares":88900},"source":{"system":"sec-edgar","filing":"0001209191-22-056842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000120919122056842/doc4.xml","form_type":"4"}},{"id":2161961,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":66506,"kind":"person","name":"Balta Elizabeth","position":1,"cik":"0001884087","reported_name":"Bekiroglu Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec."}}],"security":"Common Stock","published_at":"2022-09-09T18:44:13.000Z","date":"2022-09-08","kind":"sale","acquired":false,"shares":1813,"price":4.8731,"value":8834.9303,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to cover the applicable withholding taxes upon settlement of restricted stock units issued to the Reporting Person and was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $5.04. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":108929,"source":{"system":"sec-edgar","filing":"0001209191-22-049360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000120919122049360/doc4.xml","form_type":"4"}},{"id":2396941,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":66506,"kind":"person","name":"Balta Elizabeth","position":1,"cik":"0001884087","reported_name":"Bekiroglu Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec."}}],"security":"Common Stock","published_at":"2022-02-14T19:02:47.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":82992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") which will vest as to 25% of the total number of RSUs granted on each of the first four anniversaries of February 10, 2022, subject to the reporting persons continued service through the applicable vesting date.  Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date."}],"balance_after":110742,"source":{"system":"sec-edgar","filing":"0001209191-22-009509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000120919122009509/doc4.xml","form_type":"4"}}]}